Celly Nutrition Secures Additional Financing To Launch Unbuzzd(TM) Stick Packs This Month - Created By A World-Class Pharmaceutical Research & Development Team


(MENAFN- Newsfile Corp) Vancouver, British Columbia--(Newsfile Corp. - August 9, 2024) - Celly Nutrition Corp. (" Celly Nu " or the " Company "), which is backed by a world-class Pharmaceutical research & development team at FSD Pharma, operated by CEO John Duffy, formerly of Coca-Cola, and co-chaired by Gerry David the former CEO of Celsius Holdings (CELH) proudly announces the imminent launch of its revolutionary, great tasting and scientifically-backed product, unbuzzdTM. This milestone marks the beginning of a new era in recovery solutions with the introduction of convenient, grab-and-go stick packs. Designed by scientists for use anywhere, unbuzzdTM offers consumers an innovative approach to helping accelerate alcohol metabolism, restore mental clarity, and prepare for what's next.


Celly Nutrition Secures Additional Financing To Launch Unbuzzd(TM) Stick Packs This Month - Created By A World-Class Pharmaceutical Research & Development Team Image

To view an enhanced version of this graphic, please visit:


Celly Nutrition Secures Additional Financing To Launch Unbuzzd(TM) Stick Packs This Month - Created By A World-Class Pharmaceutical Research & Development Team Image

To view an enhanced version of this graphic, please visit:

Today's recovery drinks focus on alleviating the discomfort known as the "hangover." However, unbuzzdTM aims to reshape this paradigm. unbuzzd helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly and drink refreshingly. unbuzzd appeals to a broad target audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day.

Driven by science, unbuzzdTM is a proprietary blend of vitamins, minerals, and herbs designed to help restore mental alertness, improve cognition, and accelerate alcohol metabolism. This dual mode of action supports swift recovery from inebriation and has revolutionized alcohol consumption recovery. Our world-class R&D team has dedicated themselves to creating this on-the-go, alcohol-reducing nutraceutical.

John Duffy, CEO of Celly Nutrition, shares his excitement about this significant milestone: "I am very proud of the Celly Nu and FSD Pharma teams for delivering on our promise of a great tasting and functional product built on science. The successfully completed first production run of unbuzzdTM stick packs is one of the final steps before our August launch."

Expected to launch in three packs and eighteen packs on Amazon later this month, these compact, slender packs are easy to carry in a pocket or purse, making them perfect for any situation. Whether it's the end of a long day, a night out, a boozy lunch, the end of 18 holes, when you really enjoyed last night but your kids don't care, you are getting wine drowsy with friends, you are about to give the best man's wedding speech, your about to sit through a 3-hour show after cocktails, or just an early morning, unbuzzdTM is there to help manage the aftermath of alcohol consumption in as little as 30 minutes. Just add water, shake, and drink. It is your portable wingman for responsible alcohol consumption.

Celly Nutrition plans to add 12oz Ready to Drink (RTD) cans to the unbuzzdTM lineup later this year.

The coming launch of unbuzzdTM is being driven by the executive guidance of beverage industry luminaries like Gerry David, the former Chief Executive Officer at Celsius Holdings, Inc. where he helped build the foundation of what is today one of the most successful beverages over the past decade. In addition, John Duffy, a seasoned executive with an extensive background at Coca-Cola Enterprises and The Coca-Cola Company is leading the charge as CEO. They are actively supported by Kevin Harrington (known as the Inventor of the Infomercial, the Original Shark on Shark Tank, and the As Seen on TV Pioneer) and Dr. Eric Hoskins a Rhodes Scholar, Medical Doctor, and Ontario, Canada's former Minister of Health responsible for North America's largest health system.

In support of the upcoming launch of unbuzzdTM, the Company also announces the closing of its first round of financing (the " First Tranche "). Under the First Tranche, the Company has issued 6,833,332 common shares for gross proceeds of US$203,469. No finder's fees were paid in connection with the First Tranche.

The First Tranche comprises the initial portion of the offerings, which are hereby extended to dates the Company may designate, under which the Company is selling (i) up to US$1,000,000 common shares of the Company at a price of US$0.03 per share, and (ii) up to US$3,000,000 common shares of the Company at a price of US$0.05 per share (the " Offerings "). The net proceeds from the Offerings will be used by the Company to advance its business plans and for general working capital purposes. All securities issued under the First Tranche are subject to a hold period of four months plus one day from the closing date.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act ") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons as defined under applicable United States securities laws unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

MENAFN09082024004218003983ID1108537278


Newsfile Corp

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Newsletter